BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.

CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and ...

More than 60 companies, including Amazon, Google, UnitedHealth and Epic, have pledged to participate in the initiative, which ...

Monogram Technologies conducted its first fully autonomous robotic knee replacement surgery, while Stereotaxis won FDA ...

Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.

Executives also said demand for capital equipment continues to be healthy. However, investors may have expected stronger ...

Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and ...

The medtech firm, which previously forecast a $200 million tariff impact for 2025, also raised its earnings outlook, citing ...

This earnings season, top medical device companies have dramatically reduced their expectations for tariff impacts in 2025.

The company previously forecast an up to 300 million euro tariff impact in 2025 before the U.S. struck agreements with China ...